NPHS1
NPHS1 (nephrin; also known as CNF and NPHN) is an immunoglobulin-family cell adhesion molecule that functions in the kidney glomerular filtration barrier. It is a type-1 transmembrane protein found at the slit diaphragm of glomerular podocytes. Browse Assay Genie's current range of NPHS1 research reagents below, or read on for the biology behind the target.
NPHS1 appears to play a role in the development and function of the kidney glomerular filtration barrier, and it regulates glomerular vascular permeability. The protein is found at the slit diaphragm of glomerular podocytes, a structure thought to act as an ultrafilter that excludes albumin and other plasma macromolecules during the formation of urine. NPHS1 may also anchor the podocyte slit diaphragm to the actin cytoskeleton. Outside the kidney, nephrin has a role in skeletal muscle formation through regulation of myoblast fusion.
The NPHS1 gene encodes a member of the immunoglobulin family of cell adhesion molecules. The nephrin protein is a type-1 transmembrane protein that localises to the cell membrane, and the gene is primarily expressed in renal tissues. In HGNC, the protein is classified within the fibronectin type III domain containing, V-set domain containing and C2-set domain containing gene groups. The mouse and rat orthologues are both named Nphs1, which allows the biology of the barrier to be studied in rodent models.
NPHS1 takes its previous names from the disease it causes: nephrosis 1, congenital, Finnish type. Mutations in the gene result in Finnish-type congenital nephrosis 1, characterised by severe proteinuria and loss of the slit diaphragm and foot processes. This makes nephrin a central reference point in work on podocyte biology and the molecular basis of glomerular filtration. NPHS2 is another gene associated with the podocyte and is a related target for comparative studies.
Nephrin is a structural component of the slit diaphragm of glomerular podocytes, so it is a core target for studying the filtration barrier.
Mutations in NPHS1 cause Finnish-type congenital nephrosis, with severe proteinuria and loss of the slit diaphragm and foot processes.
NPHS1 may anchor the podocyte slit diaphragm to the actin cytoskeleton, linking an immunoglobulin-family adhesion molecule to cell architecture.
Nephrin contributes to skeletal muscle formation through regulation of myoblast fusion, extending its relevance beyond the kidney.
NPHS1 (nephrin) appears to play a role in the development and function of the kidney glomerular filtration barrier and regulates glomerular vascular permeability. It may anchor the podocyte slit diaphragm to the actin cytoskeleton, and it also contributes to skeletal muscle formation by regulating myoblast fusion.
The HGNC name is NPHS1 adhesion molecule, nephrin, and the protein is called nephrin. Aliases include CNF and NPHN. Earlier names were nephrosis 1, congenital, Finnish type (nephrin), reflecting the disease associated with mutations in the gene.
Mutations in NPHS1 result in Finnish-type congenital nephrosis 1, with severe proteinuria and loss of the slit diaphragm and foot processes. Mouse and rat both have an orthologue named Nphs1; check the datasheet of any product for its validated reactivity.
Podocyte-associated targets and other proteins involved in the kidney glomerular filtration barrier.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O60500; product specifications from Assay Genie datasheets.